PHASE-1 CLINICAL-TRIAL OF RECOMBINANT INTERLEUKIN-2 - A COMPARISON OF BOLUS AND CONTINUOUS INTRAVENOUS-INFUSION

被引：33

作者：

KOHLER, PC

HANK, JA

MOORE, KH

STORER, B

BECHHOFER, R

HONG, R

SONDEL, PM

机构：

[1] UNIV WISCONSIN,DEPT STAT,MADISON,WI 53792

[2] UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53792

[3] UNIV WISCONSIN,DEPT GENET,MADISON,WI 53792

来源：

CANCER INVESTIGATION | 1989年 / 7卷 / 03期

关键词：

D O I：

10.3109/07357908909039840

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：213 / 223

页数：11

共 28 条

[1]

ATKINS MB, 1986, J CLIN ONCOL, V4, P13809

[2] EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER [J].

BELLDEGRUN, A ;

WEBB, DE ;

AUSTIN, HA ;

STEINBERG, SM ;

WHITE, DE ;

LINEHAN, WM ;

ROSENBERG, SA .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :817-822

[3]

ETTINGHAUSEN SE, 1987, BLOOD, V69, P1654

[4] THE HUMAN LYMPHOKINE-ACTIVATED KILLER CELL SYSTEM .5. PURIFIED RECOMBINANT INTERLEUKIN-2 ACTIVATES CYTO-TOXIC LYMPHOCYTES WHICH LYSE BOTH NATURAL KILLER-RESISTANT AUTOLOGOUS AND ALLOGENEIC TUMORS AND TRINITROPHENYL-MODIFIED AUTOLOGOUS PERIPHERAL-BLOOD LYMPHOCYTES [J].

GRIMM, EA ;

WILSON, DJ .

CELLULAR IMMUNOLOGY, 1985, 94 (02) :568-578

[5] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].

GRIMM, EA ;

MAZUMDER, A ;

ZHANG, HZ ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841

[6]

GRIMM EA, 1984, LYMPHOKINES, V9, P279

[7]

HANK JA, 1988, CANCER RES, V48, P1965

[8]

LAFRENIERE R, 1985, CANCER RES, V45, P3735

[9]

LANIER LL, 1986, J IMMUNOL, V137, P2735

[10]

LOTZE MT, 1985, J IMMUNOL, V134, P157

← 1 2 3 →